Rare Diseases
91
35
39
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.2%
2 terminated out of 91 trials
90.5%
+4.0% vs benchmark
2%
2 trials in Phase 3/4
21%
4 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (91)
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
A Multi-Dimensional Model of cAre and transItion for Patients With cOmplex RAre Diseases
Longitudinal Studies of Patient With FPDMM
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability
Using Social Robots in Children With Rare Diseases and Their Parents: A Feasibility Study
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
A Longitudinal Study on Family Adaptation and Relationship Dynamics in Pediatric Rare Diseases
Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia
Rheopheresis as Adjuvant Treatment of Calciphylaxis
Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases.
Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes
Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas
Institutional Registry of Rare Diseases
Umbrella Study for Single Patient Treatments in Oncology
Rare and Undiagnosed Disease Research Biorepository
Identification of Cellular Biomarkers of Rare Eye Diseases in Adults
Swiss Rare Disease Registry (SRDR)
Evaluation of the French Version of the PEERS Social Skills Training Program for Adolescents With Rare Neurodevelopmental Disorders